Skip to content

Orthosis to Improve Trunk Control in Infants Age 6-18 Months

Assessing Functional Improvements With Use of the SPIO Core-Max Expedition TLSO

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06027580
Enrollment
30
Registered
2023-09-07
Start date
2024-02-21
Completion date
2026-08-06
Last updated
2026-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral Palsy

Keywords

abnormal muscle tone, cerebral palsy, hypotonia, muscle tone, spasticity

Brief summary

The purpose of this study is to determine the impact of the SPIO® Core-MAX® Expedition orthosis on an infant's head, trunk and upper limb function.

Detailed description

This study will observe the difference in outcomes between two courses of standard clinical care: therapy or therapy with the SPIO® Core-MAX® Expedition orthosis. Families will self-select that standard care option that works best for their family, and outcomes will be observed at baseline, 3 months and 6 months.

Interventions

DEVICESPIO® Core-MAX® Expedition thoracolumbosacral orthosis

SPIO® Core-MAX® Expedition thoracolumbosacral orthosis use 2 hours per day for 6 months

OTHERStandard Care Therapy option

Standard of care Therapy without the use of trunk orthosis

Sponsors

SPIO
CollaboratorUNKNOWN
Medical College of Wisconsin
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
6 Months to 18 Months
Healthy volunteers
No

Inclusion criteria

* Study subjects aged 6 months to 18 months age corrected with abnormal muscle tone * No previous use of SPIO® or similar Lycra/compression garments * Assessed by provider as likely to benefit from use of compression garment

Exclusion criteria

* Non-English speaking * Inability for family to bring study subject to assessments * Orthosis or casting that contraindicate SPIO® Core-MAX® during the study period * Botulinum toxin injections within 3 months, or during study participation * Having prior orthopedic or neurosurgery surgeries within one year

Design outcomes

Primary

MeasureTime frameDescription
Change in head and trunk position from centerline at baseline, 3-months and 6-months.Through study completion, an average of 2 yearsDegree change in head and trunk position from centerline as assessed by motion capture.
Change from baseline to 3-months and 6-months on the Pediatric Quality of Life Inventory Infant Scale.Through study completion, an average of 2 yearsThe Pediatric Quality of Life Inventory Infant Scales (PedQL-I) is used to assess parent-reported health-related quality of life for children with ages 1-12 months or 12-24 months. It has the same five components, including physical functioning (6 items), physical symptoms (10 items), emotional functions (12 items), social functioning (4 items), and cognitive functioning (4 items) with scale from 0 to 4. 0 if it is never a problem 1. if it is almost never a problem 2. if it is sometimes a problem 3. if it is often a problem 4. if it is almost always a problem

Countries

United States

Contacts

Primary ContactMitchell O'Neill, MD
moneill@mcw.edu414-266-4771
Backup ContactSarah Golus
sgolus@mcw.edu414-955-1923

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026